(Q41003223)

25 September 2017

1 reference

title

Cholesterol and cataracts (English)

1 reference

25 September 2017

Cenedella RJ

1

1 reference

25 September 2017

1 January 1996

1 reference

25 September 2017

Survey of Ophthalmology

1 reference

25 September 2017

40

1 reference

25 September 2017

4

1 reference

25 September 2017

320-337

1 reference

Limited proteolysis of MP26 in lens fiber plasma membranes of the U18666A-induced cataract in rats

25 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Lipid composition of chick lens fiber cell gap junctions.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Na,K-ATPase and phospholipid degradation in bovine and human lenses

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Cataracts by lipid lowering drugs? Three different HMG-CoA reductase inhibitors studied in hypercholesterolemic rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Mevalonic aciduria: an inborn error of cholesterol biosynthesis?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Induction of chronic epileptiform activity in the rat by an inhibitor of cholesterol synthesis, U18666A

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Accumulation of 7 alpha-hydroxy-4-cholesten-3-one and cholesta-4,6-dien-3-one in patients with cerebrotendinous xanthomatosis: effect of treatment with chenodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

The plasma membranes of eye lens fibres. Biochemical and structural characterization.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Long-term safety and efficacy profile of simvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Role of cholesterol in the structural order of lens membrane lipids

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Lens membranes 1. Composition of urea-treated plasma membranes from calf lens

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Composition and synthesis in vivo of water-insoluble proteins in the rat ocular lens: Normal and cataractous

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Concentration-dependent effects of AY-9944 and U18666A on sterol synthesis in brain. Variable sensitivities of metabolic steps

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Source of cholesterol for the ocular lens, studied with U18666A: a cataract-producing inhibitor of lipid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Lipoproteins and lipids in cow and human aqueous humor

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Regional distribution of lipids and phospholipase A2 activity in normal and cataractous rat lens

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Inhibitors of cholesterol synthesis and cataracts

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

On the composition and origin of the urea-soluble polypeptides of the U18666A cataract

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Mechanism of cataract production by 3-β(2-diethylaminoethoxy) androst-5-en-17-one hydrochloride, U18666A: An inhibitor of cholesterol biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Selective association of crystallins with lens 'native' membrane during dynamic cataractogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Calcium activated proteolysis and protein modification in the U18666A cataract

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Possible abnormalities of steroid secretion in children with Smith-Lemli-Opitz syndrome and their parents

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Lens opacities classification system II (LOCS II)

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Lovastatin and the human lens; results of a two year study. The MSDRL Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Cholesterol and phospholipids in protein fractions of human lens and senile cataract

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Effect of sterol structure on acyl chain ordering in phosphatidylcholine vesicles: a deuterium nuclear magnetic resonance and electron spin resonance study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Effect of alkyl-substituted precursors of cholesterol on artificial and natural membranes and on the viability of Mycoplasma capricolum

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Syndrome of retardation with urogenital and skeletal anomalies (Smith-Lemli-Opitz syndrome): clinical features and mode of inheritance.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Different effects of the hypolipidemic drugs pravastatin and lovastatin on the cholesterol biosynthesis of the human ocular lens in organ culture and on the cholesterol content of the rat lens in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Cholesterol content of the rat lens is lowered by administration of simvastatin, but not by pravastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Biosynthetic capacity of the human lens upon aging

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

The state of neutral lipids in normal and cataractous human lenses

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Relationship of cholesterolgenesis to DNA synthesis and proliferation by lens epithelial cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Efficacy and safety of simvastatin (alone or in association with cholestyramine). A 1-year study in 66 patients with type II hyperlipoproteinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Cataracts in a girl with features of the Smith-Lemli-Opitz syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Specific restriction of cholesterol from cortical lens gap junctional membrane in the U18666A cataract

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Isolation of a non-sedimenting membrane fraction from the water soluble fraction of bovine lens

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Tissue selectivity of the cholesterol-lowering agents lovastatin, simvastatin and pravastatin in rats in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Animal safety and toxicology of simvastatin and related hydroxy-methylglutaryl-coenzyme A reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

On the etiology of subcapsular lenticular opacities produced in dogs receiving HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Membrane-bound domain of HMG CoA reductase is required for sterol-enhanced degradation of the enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Regulation of the mevalonate pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Lens metabolic cooperation: a study of mouse lens transport and permeability visualized with freeze-substitution autoradiography and electron microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

HMG-CoA reductase inhibitors for treatment of hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

The reversal of triparanol induced cataracts in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia. A multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

HMG CoA reductase activity of lens epithelial cells: compared with true rates of sterol synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Mevalonic aciduria--an inborn error of cholesterol and nonsterol isoprene biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 4. Side chain ester derivatives of mevinolin

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Effects of long-term administration of HMG-CoA reductase inhibitors on cholesterol synthesis in lens

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Near normal levels of isoprenoid lipids in severe mevalonic aciduria

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Cataract Formation After Triparanol Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Ocular Manifestations of the Smith-Lemli-Opitz Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Cerebrotendinous xanthomatosis: clinical and biochemical evaluation of eight patients and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

The surface morphology of embryonic and adult chick lens‐fiber cells

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

A correlative freeze-etch and electrophysiological study of communicating junctions in crystalline lenses

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

The human lens after 48 weeks of treatment with lovastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Expanded clinical evaluation of lovastatin (EXCEL) study results. II. Assessment of the human lens after 48 weeks of treatment with lovastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Cataracts in Patients Treated with Triparanol

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Lens opacity in patients with hypercholesterolemia and ischaemic heart disease. Electronic lens opacity measurements

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Age dependent lipid and protein changes in individual bovine lenses

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Age-dependent changes in the distribution and concentration of human lens cholesterol and phospholipids

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

A multicenter comparison of lovastatin and probucol for treatment of severe primary hypercholesterolemia. The Lovastatin Study Group IV

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Lens changes in matched normals and hyperlipidemic patients treated with simvastatin for 2 years

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Perspective on cataractogenic potential of HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Preclinical evaluation of lovastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

A case of cerebrotendinous xanthomatosis. II: The sterol content of a cataractous lens

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Lipid composition and ( activity in rat lens during triparanol-induced cataract formation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Long-term efficacy and safety of simvastatin alone and in combination therapy in treatment of hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Smith-Lemli-Opitz (RSH) syndrome bibliography

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Myotonia induced by diazacholesterol: increased (Na+ + K+)-ATPase activity of erythrocyte ghosts and development of cataracts

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Novel morphological changes in rat retina induced by intravitreal injection of lovastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Physical properties of membranes and membrane lipids from the fiber cell of the U18666A-cataractous rat

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Lipids in tissues of the eye. XII. Phospholipid and sphingomyelin concentrations in bovine lenses in relation to differentiation and ageing

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Changes in lipid distribution in the human lens with the development of cataract

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Relationship between tissue selectivity and lipophilicity for inhibitors of HMG-CoA reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Lens plasma membrane: isolation and biochemical characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Niemann-Pick disease experimental model: sphingomyelinase reduction induced by AY-9944.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Gangliosides in normal and cataractous lenses of several species

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Ocular drug safety and HMG-CoA-reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

The ultrastructure of lens and iris in cerebrotendinous xanthomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

A biochemical abnormality in cerebrotendinous xanthomatosis. Impairment of bile acid biosynthesis associated with incomplete degradation of the cholesterol side chain

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Effects of 3 beta-[2-(diethylamino)ethoxy]androst-5-en-17-one on the synthesis of cholesterol and ubiquinone in rat intestinal epithelial cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Tissue selectivity of hydroxymethylglutaryl coenzyme A (HMG CoA) reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

A NEWLY RECOGNIZED SYNDROME OF MULTIPLE CONGENITAL ANOMALIES.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

EFFECTS OF TRIPARANOL (MER-29) ON CHOLESTEROL BIOSYNTHESIS AND ON BLOOD STEROL LEVELS IN MAN

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Reproducing abnormal cholesterol biosynthesis as seen in the Smith-Lemli-Opitz syndrome by inhibiting the conversion of 7-dehydrocholesterol to cholesterol in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Cholesterol and the cell membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Lanosterol and cholesterol have different effects on phospholipid acyl chain ordering

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

Glucose transport through cell membranes of modified lipid fluidity

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982007-8

1 reference

7 January 2021

10.1016/S0039-6257(96)82007-8

Identifiers

DOI

1 reference

25 September 2017

1 reference

PubMed ID

8658343